An Extension Study for Patients Previously Treated With ARQ 501.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2013
At a glance
- Drugs Beta lapachone (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors ArQule
- 08 Jan 2009 Planned patient number added (1) as reported by ClinicalTrials.gov.
- 08 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2008 New trial record.